CRMD(CorMedix Inc.) · 财务报表

CRMD(CorMedix Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2020-12-31FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$239.23K$190.94K$65.41K$43.47M$311.71M
毛利润$34.38K$42.00K$61.67K$40.28M$275.75M
营业利润−$27.22M−$29.44M−$30.62M−$22.36M$150.14M
净利润−$22.03M−$28.21M−$29.70M−$17.93M$163.06M
经营现金流−$21.97M−$21.16M−$24.36M−$50.62M$175.05M
自由现金流−$22.08M−$22.58M−$24.58M−$50.73M$172.79M
摊薄每股收益$-0.77$-0.75$-0.74$-0.30$2.04

CorMedix Inc. CRMD